Pfizer has announced its reorganization strategy with Wyeth. The research operations will be broken into two units: a biotechnology unit led by a Wyeth senior executive, and a pharmaceutical group led by a Pfizer scientist. The plan hopes to smoothly integrate Pfizer and Wyeth … [Read more...] about Pfizer’s Reorg Focuses on Biotech
Pfizer
Merck Puts Some of Their Gardasil Cash To Work
Merck to buy Schering-Plough in $41 billion deal Reported by David Jolly Publ With the purchase, Merck is expanding its franchise in cardiovascular, respiratory and oncology drugs and shoring up its research pipeline, in particular with a Schering-Plough product called TRA, a … [Read more...] about Merck Puts Some of Their Gardasil Cash To Work